Pharma & Biotech

The biotechnology firm aTyr Pharma faces an unprecedented crisis as its stock value collapses and legal challenges mount. This dramatic...

Keros Therapeutics Inc. has become the center of intense market attention following the announcement of a substantial capital return program...

The biotechnology sector has found a promising contender in Axsome Therapeutics. This US-based pharmaceutical company continues to post impressive achievements...

While much of the biotechnology sector is focused on the upcoming ESMO congress in Berlin, Incyte has already scored a...

The biotechnology sector has identified its latest standout performer: Ideaya Biosciences. While numerous companies in the space face developmental challenges,...

Danaher Corporation faces heightened investor scrutiny as a legal investigation emerges just days before the company's critical third-quarter earnings announcement....

The biotechnology firm Atossa Therapeutics is positioning itself for a significant transition, yet market participants remain divided on its prospects....

Generation Bio shares are experiencing extreme volatility as the biotechnology firm undergoes a dramatic corporate transformation. Facing an existential challenge,...

Novo Nordisk finds itself navigating one of its most challenging periods, as the Danish pharmaceutical giant contends with a rapidly...

The proposed acquisition of CureVac by its larger competitor BioNTech has moved significantly closer to completion following a crucial regulatory...